Harry Gruber

The biotech firm Tocagen Inc. plans an Initial Public Offering to finance ongoing clinical trials of a technique that uses a weaponized virus to help the body’s immune system battle a common and deadly type of brain cancer. San Diego-based Tocagen has applied for a listing on the Nasdaq with...